Cardiology navigation system maker Stereotaxis plans IPO (initial public offering)
This article was originally published in Clinica
Stereotaxis, the St Louis, Missouri-based firm that has developed a remote digital control navigation system for cardiovascular procedures in the cath lab, has filed for an initial public offering on Nasdaq. The issue will raise up to $115m, but the company has not yet finalised the terms and timing of the transaction.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.